|
|
Volumn 1, Issue 3, 2008, Pages 329-
|
|
Antithrombotic Therapy Use After Percutaneous Coronary Intervention and Stent Implantation in Patients Taking Chronic Oral Anticoagulation
a
a
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
WARFARIN;
ACUTE CORONARY SYNDROME;
ANTICOAGULANT THERAPY;
BLEEDING;
CARDIOVASCULAR RISK;
CEREBROVASCULAR ACCIDENT;
COMORBIDITY;
DISEASE ASSOCIATION;
DRUG INDICATION;
DRUG SAFETY;
DRUG USE;
FOLLOW UP;
HEART ATRIUM FIBRILLATION;
HEART VALVE PROSTHESIS;
HIGH RISK POPULATION;
HUMAN;
INTRACARDIAC THROMBOSIS;
LETTER;
LONG TERM CARE;
MORTALITY;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
REGISTER;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SAMPLE SIZE;
STENT;
TREATMENT RESPONSE;
VENOUS THROMBOEMBOLISM;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTICOAGULANTS;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FIBRINOLYTIC AGENTS;
HEMORRHAGE;
HUMANS;
PATIENT SELECTION;
PLATELET AGGREGATION INHIBITORS;
RISK ASSESSMENT;
STENTS;
TIME FACTORS;
|
|
EID: 44949215727
PISSN: 19368798
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcin.2008.03.016 Document Type: Letter |
|
Times cited : (1)
|
|
References (5)
|
